BioCentury
ARTICLE | Company News

FDA accepts Sumavel DosePro response

February 19, 2009 2:34 AM UTC

Zogenix (San Diego, Calif.) said FDA accepted the company's complete response for Sumavel DosePro sumatriptan for the acute treatment of migraine attacks with or without aura and for the acute treatme...